WebNov 18, 2024 · Pear Therapeutics Inc’s Somryst, the first prescription digital therapeutic (PDT) intended for use in the treatment of patients 22 years of age and older with chronic … WebWe published a real-world health economic study of Somryst, with data showing clinically meaningful reductions in health-related services and costs in the 24-months after Somryst initiation compared to 24-months prior, including an …
Pear Therapeutics Announces Formulary Availability for its Three …
WebSomryst is a prescription-only digital therapeutic intended to provide a neurobehavioral intervention (Cognitive Behavioral Therapy for Insomnia – CBT-I) in patients 22 years of age and older with chronic insomnia. … WebDec 2, 2024 · Areas covered: This review summarizes the mechanisms of action and technical features of Somryst, and describes safety and effectiveness data from the … heritage health relias training
I tried to hack my insomnia with technology. Here’s what …
WebThe number of patients treated with sleep aid medications dropped 18.5% (52.4% pre-index vs 42.7% post-index). Average number of prescriptions decreased from 3.98 pre-index to 3.73 post-index ( P = 0.552). Total two-year cost reduction post-index vs pre-index was $510,678, or -$2059 per patient. Conclusion: In a real-world cohort of patients ... WebJun 3, 2024 · This new study will use a novel patient-centered data-sharing platform with linkage to Fitbit. The new platform with Fitbit integration is called “Hugo.” Half of the … WebMay 14, 2024 · Per-member-per-month costs in the analysis were –$0.01, –$0.09, and –$0.19 over each of the 3 years (respectively) for payers and –$0.03, –$0.10, and –$0.21 for employers. On a per ... matua marlborough rose